Jiangsu Hengrui Pharmaceuticals Co.,Ltd (HKG:1276)

HKG:1276 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	450,966	310,587	316,838	277,811	396,571	702,753
Market Cap Growth	33.11%	-1.97%	14.05%	-29.95%	-43.57%	62.99%
Enterprise Value	407,071	286,905	298,159	258,198	375,624	684,268
PE Ratio	55.25	46.06	66.85	62.91	71.32	93.51
PS Ratio	13.32	10.43	12.60	11.55	12.47	21.34
PB Ratio	6.87	6.33	7.01	6.40	9.08	19.22
P/TBV Ratio	7.11	6.58	7.27	6.59	9.35	19.62
P/FCF Ratio	42.15	53.52	46.69	-	126.49	205.64
P/OCF Ratio	34.54	39.32	37.63	194.22	76.58	172.42
EV/Sales Ratio	11.93	9.63	11.86	10.74	11.81	20.78
EV/EBITDA Ratio	42.87	37.48	55.89	63.46	71.83	85.74
EV/EBIT Ratio	47.32	41.63	64.81	74.65	81.29	91.87
EV/FCF Ratio	38.05	49.44	43.94	-	119.81	200.23
Debt / Equity Ratio	0.00	0.00	0.00	0.04	0.00	-
Debt / EBITDA Ratio	0.01	0.02	0.02	0.37	0.04	-
Debt / FCF Ratio	0.01	0.02	0.01	-	0.06	-
Asset Turnover	0.53	0.60	0.53	0.52	0.70	0.89
Inventory Turnover	1.61	1.64	1.50	1.44	1.80	1.98
Quick Ratio	5.95	8.62	10.74	7.36	7.72	6.70
Current Ratio	6.55	9.72	12.25	8.50	8.88	7.44
Return on Equity (ROE)	14.34%	14.55%	10.77%	10.31%	13.51%	22.64%
Return on Assets (ROA)	8.37%	8.62%	6.06%	4.69%	6.36%	12.59%
Return on Capital (ROIC)	9.34%	9.27%	6.45%	5.07%	7.07%	14.07%
Return on Capital Employed (ROCE)	12.90%	13.90%	10.10%	7.90%	10.50%	20.30%
Earnings Yield	1.81%	2.17%	1.50%	1.59%	1.40%	1.07%
FCF Yield	2.37%	1.87%	2.14%	-0.30%	0.79%	0.49%
Payout Ratio	17.06%	20.12%	23.77%	26.00%	23.54%	16.07%
Buyback Yield / Dilution	-1.59%	-0.15%	1.20%	-0.36%	0.18%	0.03%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.